by: Amitava Banerjee The countries which have been unable to suppress SARS-CoV-2 infection rate have had to focus health systems and resources on the acute hospitalised phase of COVID-19, particularly in the intensive care unit. However, most hospital care of COVID is not in intensive care, and most COVID patients, even in high-income settings, areContinue reading “The long cardiovascular tail of the pandemic”
Tag Archives: Cardiology
Do COVID STEMIs have a higher thrombus burden? More questions & implications
by:Aaysha Cader Whilst much has been written about COVID-19 and its inflammation-thrombosis-hypercoagulability cascade, this has to a large extent focused on venous thromboembolism (VTE). As more data emerges, it is evident that the intense inflammatory response associated with SARS-COV-2 infection may trigger thrombosis across multiple vascular beds, with large thrombus burden in ST-segment elevation myocardialContinue reading “Do COVID STEMIs have a higher thrombus burden? More questions & implications”
Association of renin-angiotensin system inhibitors with severity and outcomes of COVID-19 infection in hospitalized patients with hypertension
byLucrecia M. Burgos Angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) are not associated with severity and outcomes of coronavirus disease 2019 (COVID-19) infection in hospitalized patients with hypertension in Wuhan, China according to a recent study in JAMA Cardiology1. In this retrospective single-centre analysis, the authors analysed hospitalized patients with COVID-19 at the Central HospitalContinue reading “Association of renin-angiotensin system inhibitors with severity and outcomes of COVID-19 infection in hospitalized patients with hypertension”
Impact of the COVID-19 pandemic on interventional cardiology activity
by:Lucrecia Maria Burgos An important reduction in the activity in interventional cardiology has been observed during the COVID-19 epidemic according to a recent study in REC Interventional Cardiology1. The authors carried out a survey in 81 centres involved in ST-elevation myocardial infarction (STEMI) networks in the 17 autonomous communities of Spain. Information was collected on diagnosticContinue reading “Impact of the COVID-19 pandemic on interventional cardiology activity”
Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
by:Lucrecia M. Burgos Patients with previous cardiovascular metabolic diseases may face a greater risk of developing into the severe condition and the comorbidities can also greatly affect the prognosis of the 2019 novel corona virus (2019-nCoV) disease (COVID-19). On the other hand, COVID-19 can, in turn, aggravate the damage to the heart, according to aContinue reading “Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China”
Should cardiovascular disease comorbidity scare you during the COVID-19 season?
by: Dr. Jeemon Panniyammakal, PhD, MPH, FESC The SARS-CoV-2 infection (corona virus infection) spread has reached pandemic proportions. Globally, as on 31 March, 2020 nearly 0.8 million corona virus disease (COVID-19) cases and 38,000 related deaths are reported. Countries around the world are particularly “shielding” or “protecting” individuals with cardiovascular disease (CVD) from external exposureContinue reading “Should cardiovascular disease comorbidity scare you during the COVID-19 season?”
Can the fear of COVID-19 lead to harmful delays in seeking care for cardiovascular emergencies?
by: Darryl Leong The impact of COVID-19 on the delivery of care for emergency cardiovascular illness is unknown. In this report, Tam, et al. describe the timeliness of primary percutaneous coronary intervention for ST elevation myocardial infarction (STEMI) in 7 consecutive patients presenting to a single centre in Hong Kong, China, between January 25, andContinue reading “Can the fear of COVID-19 lead to harmful delays in seeking care for cardiovascular emergencies?”